{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:49:06Z","timestamp":1792446546460,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bpa.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T07:45:17Z","timestamp":1498203917000},"page":"201-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Postoperative management of heart transplantation patients"],"prefix":"10.1016","volume":"31","author":[{"given":"Eleanor","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Schroder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Nicoara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.bpa.2017.06.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13199","article-title":"OPTN\/SRTR 2013 annual data report: heart","volume":"15","author":"Colvin-Adams","year":"2015","journal-title":"Am J Transpl"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The registry of the International society for heart and lung transplantation: thirty-third adult heart transplantation report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"8","key":"10.1016\/j.bpa.2017.06.002_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International society of heart and lung transplantation guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"7","key":"10.1016\/j.bpa.2017.06.002_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/echo.12605","article-title":"Role of echocardiography in the treatment of cardiac tamponade","volume":"31","author":"Chandraratna","year":"2014","journal-title":"Echocardiography"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ehjci\/jeu210","article-title":"The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the acute cardiovascular care association","volume":"16","author":"Lancellotti","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.healun.2014.02.027","article-title":"Report from a consensus conference on primary graft dysfunction after cardiac transplantation","volume":"33","author":"Kobashigawa","year":"2014","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.bpa.2017.06.002_bib7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.healun.2011.01.721","article-title":"RADIAL: a novel primary graft failure risk score in heart transplantation","volume":"30","author":"Segovia","year":"2011","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.bpa.2017.06.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2017.02.014","article-title":"Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: epidemiology, risk factors, and outcomes","author":"Sabatino","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.bpa.2017.06.002_bib9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.healun.2013.08.004","article-title":"Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score","volume":"32","author":"Cosio Carmena","year":"2013","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jtcvs.2012.09.037","article-title":"Primary graft dysfunction does not lead to increased cardiac allograft vasculopathy in surviving patients","volume":"145","author":"Kwon","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib11","first-page":"263","article-title":"Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre","volume":"51","author":"Squiers","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.transproceed.2013.11.107","article-title":"Risk factors and prognosis of patients with primary graft failure after heart transplantation: an Asian center experience","volume":"46","author":"Chen","year":"2014","journal-title":"Transpl Proc"},{"issue":"6","key":"10.1016\/j.bpa.2017.06.002_bib13","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.transproceed.2016.02.073","article-title":"Clinical factors implicated in primary graft dysfunction after heart transplantation: a single-center experience","volume":"48","author":"Quintana-Quezada","year":"2016","journal-title":"Transpl Proc"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/TP.0b013e3181e6f1eb","article-title":"Factors associated with primary graft failure after heart transplantation","volume":"90","author":"Russo","year":"2010","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","article-title":"The registry of the International society for heart and lung transplantation: 29th official adult heart transplant report\u20132012","volume":"31","author":"Stehlik","year":"2012","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ejhf.478","article-title":"Contemporary management of acute right ventricular failure: a statement from the heart failure association and the working group on pulmonary circulation and right ventricular function of the European Society of Cardiology","volume":"18","author":"Harjola","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ane.0b013e31818d8b92","article-title":"The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management","volume":"108","author":"Haddad","year":"2009","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.bpa.2017.06.002_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1213\/ane.0b013e31818f8623","article-title":"The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment","volume":"108","author":"Haddad","year":"2009","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.bpa.2017.06.002_bib20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jtcvs.2009.04.063","article-title":"A\u00a0prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients","volume":"138","author":"Khan","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A\u00a0randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00000539-200003000-00005","article-title":"Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation","volume":"90","author":"Rajek","year":"2000","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.bpa.2017.06.002_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1053-0770(96)80047-4","article-title":"Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study","volume":"10","author":"Haraldsson","year":"1996","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1399-6576.2006.01139.x","article-title":"Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction","volume":"50","author":"Theodoraki","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"10.1016\/j.bpa.2017.06.002_bib25","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0003-4975(00)01864-6","article-title":"Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation","volume":"70","author":"Arafa","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"10.1016\/j.bpa.2017.06.002_bib26","article-title":"Early denervation and later reinnervation of the heart following cardiac transplantation: a review","volume":"5","author":"Awad","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib27","article-title":"Arrhythmias after heart transplantation: mechanisms and management","volume":"1","author":"Thajudeen","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9149(01)01641-1","article-title":"Increased incidence of atrial flutter associated with the rejection of heart transplantation","volume":"88","author":"Cui","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bpa.2017.06.002_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/TCRM.S126869","article-title":"The influence of surgical technique on early posttransplant atrial fibrillation \u2013 comparison of biatrial, bicaval, and total orthotopic heart transplantation","volume":"13","author":"Rivinius","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/pace.13021","article-title":"A\u00a0single center study of 1,179 heart transplant patients-factors affecting pacemaker implantation","volume":"40","author":"Wellmann","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"issue":"11","key":"10.1016\/j.bpa.2017.06.002_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.hrthm.2010.06.026","article-title":"Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS\/OPTN cardiac transplant database","volume":"7","author":"Cantillon","year":"2010","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2010.04.029","article-title":"Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database","volume":"140","author":"Davies","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"23","key":"10.1016\/j.bpa.2017.06.002_bib33","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2008.02.065","article-title":"Supraventricular tachycardia after orthotopic cardiac transplantation","volume":"51","author":"Vaseghi","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.bpa.2017.06.002_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1540-8167.2006.00497.x","article-title":"Incidence of atrial fibrillation in heart transplant patients: long-term follow-up","volume":"17","author":"Khan","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.bpa.2017.06.002_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2010.04.035","article-title":"Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation","volume":"106","author":"Dasari","year":"2010","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.healun.2005.07.017","article-title":"Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter","volume":"25","author":"Ahmari","year":"2006","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.transproceed.2012.09.116","article-title":"Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients","volume":"45","author":"Chang","year":"2013","journal-title":"Transpl Proc"},{"issue":"11","key":"10.1016\/j.bpa.2017.06.002_bib38","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"24","key":"10.1016\/j.bpa.2017.06.002_bib39","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1161\/01.CIR.0000149745.83186.89","article-title":"Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.bpa.2017.06.002_bib40","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1161\/01.CIR.0000150332.42276.69","article-title":"Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bpa.2017.06.002_bib41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2011.01.716","article-title":"Antithymocyte globulin induction therapy for adult heart transplantation: a UK National study","volume":"30","author":"Emin","year":"2011","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"12","key":"10.1016\/j.bpa.2017.06.002_bib42","article-title":"Immunosuppressive T-cell antibody induction for heart transplant recipients","author":"Penninga","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002252","article-title":"Induction therapy with antithymocyte globulin in patients undergoing cardiac transplantation is associated with decreased coronary plaque progression as assessed by intravascular ultrasound","volume":"9","author":"Azarbal","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ctr.12469","article-title":"Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents","volume":"29","author":"Whitson","year":"2015","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/152692480901900408","article-title":"Induction immunosuppression for orthotopic heart transplantation: a review","volume":"19","author":"Ensor","year":"2009","journal-title":"Prog Transpl"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2217\/imt.13.163","article-title":"Immunosuppression following heart transplantation: prospects and challenges","volume":"6","author":"Chang","year":"2014","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.bpa.2017.06.002_bib47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.healun.2007.05.002","article-title":"Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy","volume":"26","author":"Mattei","year":"2007","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"9","key":"10.1016\/j.bpa.2017.06.002_bib48","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.healun.2004.09.010","article-title":"A\u00a0multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation","volume":"24","author":"Mehra","year":"2005","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib49","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.healun.2015.04.001","article-title":"Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab","volume":"34","author":"Ansari","year":"2015","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"5","key":"10.1016\/j.bpa.2017.06.002_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1510\/icvts.2004.105262","article-title":"Induction immunosuppression after heart transplantation: monoclonal vs. polyclonal antithymoglobulins. Is there a difference?","volume":"4","author":"Haddad","year":"2005","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib51","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0041-1345(02)02640-4","article-title":"Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients","volume":"34","author":"Teebken","year":"2002","journal-title":"Transpl Proc"},{"issue":"6","key":"10.1016\/j.bpa.2017.06.002_bib52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","article-title":"Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients\u2013a large European trial","volume":"6","author":"Grimm","year":"2006","journal-title":"Am J Transpl"},{"issue":"1\u20132","key":"10.1016\/j.bpa.2017.06.002_bib53","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0041-1345(01)01906-6","article-title":"Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?","volume":"33","author":"Groetzner","year":"2001","journal-title":"Transpl Proc"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/TP.0b013e318277e378","article-title":"Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation","volume":"95","author":"Guethoff","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.healun.2008.10.004","article-title":"Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis","volume":"28","author":"Ye","year":"2009","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"12","key":"10.1016\/j.bpa.2017.06.002_bib56","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00228-010-0902-6","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials","volume":"66","author":"Penninga","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","article-title":"A\u00a0randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus","volume":"18","author":"Taylor","year":"1999","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib58","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2005.11.452","article-title":"Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3 Suppl.","key":"10.1016\/j.bpa.2017.06.002_bib59","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.TP.0000153302.27299.16","article-title":"Long-term benefits of mycophenolate mofetil after heart transplantation","volume":"79","author":"Keogh","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.bpa.2017.06.002_bib60","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.transproceed.2009.06.031","article-title":"Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation","volume":"41","author":"Dandel","year":"2009","journal-title":"Transpl Proc"},{"issue":"5","key":"10.1016\/j.bpa.2017.06.002_bib61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.bpa.2017.06.002_bib62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.healun.2012.01.002","article-title":"Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study","volume":"31","author":"Potena","year":"2012","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"8","key":"10.1016\/j.bpa.2017.06.002_bib63","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.healun.2011.12.010","article-title":"Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate","volume":"31","author":"Arora","year":"2012","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"9","key":"10.1016\/j.bpa.2017.06.002_bib65","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.transproceed.2012.09.045","article-title":"Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients","volume":"44","author":"Kaplinsky","year":"2012","journal-title":"Transpl Proc"},{"issue":"5","key":"10.1016\/j.bpa.2017.06.002_bib66","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.healun.2014.11.025","article-title":"De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation\u20138-year results","volume":"34","author":"Guethoff","year":"2015","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib67","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.healun.2014.08.003","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report\u20132014; focus theme: retransplantation","volume":"33","author":"Lund","year":"2014","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"5","key":"10.1016\/j.bpa.2017.06.002_bib68","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/tri.12284","article-title":"Acute cellular rejection the first year after heart transplantation and its impact on survival: a single-centre retrospective study at Skane University Hospital in Lund 1988\u20132010","volume":"27","author":"Soderlund","year":"2014","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.bpa.2017.06.002_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.healun.2016.08.008","article-title":"Association of recipient age and causes of heart transplant mortality: implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry","volume":"36","author":"Wever-Pinzon","year":"2017","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.healun.2010.08.029","article-title":"Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data","volume":"30","author":"George","year":"2011","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"18","key":"10.1016\/j.bpa.2017.06.002_bib71","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bpa.2017.06.002_bib72","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.bpa.2017.06.002_bib73","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib74","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.transproceed.2004.10.048","article-title":"Incidence of acute cellular rejection and non-cellular rejection in cardiac transplantation","volume":"36","author":"Subherwal","year":"2004","journal-title":"Transpl Proc"},{"issue":"8","key":"10.1016\/j.bpa.2017.06.002_bib75","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.healun.2009.04.035","article-title":"Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection","volume":"28","author":"Kfoury","year":"2009","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"12","key":"10.1016\/j.bpa.2017.06.002_bib76","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.healun.2007.09.011","article-title":"Early screening for antibody-mediated rejection in heart transplant recipients","volume":"26","author":"Kfoury","year":"2007","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humimm.2010.10.013","article-title":"Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival","volume":"72","author":"Ho","year":"2011","journal-title":"Hum Immunol"},{"issue":"9","key":"10.1016\/j.bpa.2017.06.002_bib78","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.healun.2016.04.007","article-title":"The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection","volume":"35","author":"Clerkin","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"9","key":"10.1016\/j.bpa.2017.06.002_bib79","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/j.transproceed.2016.10.002","article-title":"De novo anti-HLA antibodies after heart transplantation are associated with adverse events in the long-term follow-up of cardiac transplant recipients","volume":"48","author":"Sole-Gonzalez","year":"2016","journal-title":"Transpl Proc"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib80","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","article-title":"HLA and MICA: targets of antibody-mediated rejection in heart transplantation","volume":"91","author":"Zhang","year":"2011","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.bpa.2017.06.002_bib81","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.humimm.2009.06.015","article-title":"Alloantibodies in heart transplantation","volume":"70","author":"Ho","year":"2009","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.bpa.2017.06.002_bib82","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1053-2498(02)00472-2","article-title":"Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease","volume":"22","author":"Michaels","year":"2003","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"8","key":"10.1016\/j.bpa.2017.06.002_bib83","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2016.05.001","article-title":"Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant","volume":"35","author":"Ko","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"8","key":"10.1016\/j.bpa.2017.06.002_bib84","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.tp.0000180564.14050.49","article-title":"The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome","volume":"80","author":"Tambur","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.bpa.2017.06.002_bib85","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.healun.2010.08.026","article-title":"New-onset graft dysfunction after heart transplantation\u2013incidence and mechanism-related outcomes","volume":"30","author":"Shahzad","year":"2011","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"5","key":"10.1016\/j.bpa.2017.06.002_bib86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.healun.2009.01.015","article-title":"Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes","volume":"28","author":"Wu","year":"2009","journal-title":"J\u00a0Heart Lung Transpl"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689617300381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689617300381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:21:12Z","timestamp":1776410472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689617300381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1521689617300381"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2017.06.002","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative management of heart transplantation patients","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}